CNS Pharmaceuticals Inc
CNSP
CNS Pharmaceuticals Inc AI Insights
Informational only. Not investment advice.Snapshot
- Zero revenue TTM with 16.2M cash burn - 9.9M cash provides ~7 months runway at current rate[Cash and Equivalents / Free Cash Flow TTM]
- R&D spend of 8.1M TTM is 61% of total opex - clinical-stage focus with binary outcome risk[Research and Development TTM]
- Market cap 3.6M vs book value 9.9M yields P/B of 0.37 - trading below liquidation value[Price to Book Ratio]
Watch Triggers
- Cash and Equivalents: Falls below 5M — Triggers emergency financing at worst terms - expect 50%+ dilution
- Issuance of Capital Stock: Any new equity raise announced — Timing and terms of raise determine shareholder outcome
- Research and Development TTM: Significant reduction from 8.1M — Pipeline pause signals trial failure or pivot
Bull Case
Trading at 0.37x book with 9.9M tangible equity - if pipeline has any value, current price implies zero optionality
Near-zero debt (31K) means dilution is only funding path - no bankruptcy risk from creditors
Bear Case
7-month cash runway with zero revenue - imminent dilutive financing will crush existing shareholders
ROE of -197% and ROIC of -196% TTM - destroying capital with no path to profitability visible
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage CNSP's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Capital raise required within 6-9 months or operations cease
- Cash burn of 16.2M/year vs 9.9M cash
- Zero revenue with no near-term commercialization
- Minimal debt capacity (0.003 D/E)
Public Strategies Rankings
See how CNS Pharmaceuticals Inc ranks across different investment strategies.
Leverage CNSP's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
CNSP Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$3.46M | — | ||
$-6.37M | — | ||
0.01 | — | ||
$0 | — | ||
$776.03 | — | ||
0% | 0.0% | — | |
0% | 0.0% | — | |
$-16.23M | — | ||
-2.0 | — | ||
Beta 5Y (Monthly) | unknown | — |
CNSP Dividend History
CNSP Stock Splits
CNSP SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
11/14/25 | 09/30/25 | 10-Q | |
08/14/25 | 06/30/25 | 10-Q | |
05/15/25 | 03/31/25 | 10-Q | |
03/31/25 | 12/31/24 | Unknown | |
11/14/24 | 09/30/24 | 10-Q | |
08/14/24 | 06/30/24 | 10-Q | |
05/15/24 | 03/31/24 | 10-Q | |
04/01/24 | 12/31/23 | 10-K | |
11/14/23 | 09/30/23 | 10-Q | |
08/14/23 | 06/30/23 | 10-Q | |
05/15/23 | 03/31/23 | 10-Q | |
03/31/23 | 12/31/22 | 10-K | |
11/10/22 | 09/30/22 | 10-Q | |
08/12/22 | 06/30/22 | 10-Q | |
05/13/22 | 03/31/22 | 10-Q | |
03/03/22 | 12/31/21 | 10-K | |
11/12/21 | 09/30/21 | 10-Q | |
08/13/21 | 06/30/21 | 10-Q | |
05/13/21 | 03/31/21 | 10-Q | |
02/12/21 | 12/31/20 | 10-K | |
11/12/20 | 09/30/20 | 10-Q | |
08/10/20 | 06/30/20 | 10-Q | |
05/15/20 | 03/31/20 | 10-Q | |
03/12/20 | 12/31/19 | 10-K | |
12/20/19 | 09/30/19 | 10-Q | |
11/08/19 | 06/30/19 | 424B4 | |
05/15/20 | 03/31/19 | 10-Q | |
11/08/19 | 12/31/18 | 424B4 | |
12/20/19 | 09/30/18 | 10-Q | |
11/08/19 | 06/30/18 | 424B4 |